meta_pixel
Tapesearch Logo
Log in
Bloomberg Surveillance

Surveillance: Eli Lilly CEO Sees Brighter Future

Bloomberg Surveillance

Bloomberg

Business News, News, Investing, Business

3.81.2K Ratings

🗓️ 10 November 2020

⏱️ 28 minutes

🧾️ Download transcript

Summary

David Ricks, Eli Lilly Chairman & CEO, discusses the drugmaker’s Covid-19 antibody therapy that was granted emergency-use authorization in the U.S. Subadra Rajappa, Societe Generale Head of U.S. Rates Strategy, sees a departure from bonds into risky assets with a lot of cash on the sidelines that needs to be put to work. Kathy Hochul, New York Lieutenant Governor, says having a vaccine does not take the pressure off of further stimulus at all. Sam Stovall, CFRA Chief Investment Strategist, says Wall Street is looking beyond a coronavirus spike with vaccine developments appearing positive.

See omnystudio.com/listener for privacy information.

Transcript

Click on a timestamp to play from that location

0:00.0

Together we have the opportunity to build a more sustainable and inclusive future.

0:06.0

At the Bloomberg New Economy Forum, we help make this possibility a reality

0:11.0

by cultivating new connections among global leaders that transcend geographies, industries

0:16.3

and ideologies.

0:18.4

Because when global leaders work together, the outcomes benefit all of us.

0:23.0

Learn more at Bloomberg surveillance podcast. I'm Tom Keene.

0:43.3

Daily, we bring you insight from the best in economics, finance,

0:46.9

investment, and international relations.

0:49.7

Find Bloomberg Surveillance on Apple Podcasts, SoundCloud, Bloomberg.com, and of course, on the

0:56.2

Bloomberg.

0:57.2

Let's do this.

0:58.2

Let's dispense with the formalities right now and get to David Rick's Eli, Lily,

1:01.6

Chairman and CEO, and I do this. John and Lisa have a lot of questions

1:05.3

about the news yesterday, but David I think there's massive confusion over all of these fancy

1:12.3

words and particularly around vaccine or

1:15.0

around antibody treatment.

1:16.7

We conflate bacterial and virus therapies on top of each other.

1:21.8

How does a vaccine differ from the antibody treatment you announced yesterday?

1:27.0

Well, thanks for me on, Tom. And exciting news last night with the emergency use authorization in the US for our monoclonal

1:34.6

antibody, neutralizing antibody, which is a therapy that you're to be given in

1:40.1

this approval if you have new newer onset disease,

1:44.0

so a positive test and symptoms,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.